The multidisciplinary management of rectal cancer

KL Meredith, SE Hoffe, D Shibata - Surgical Clinics of North America, 2009 - Elsevier
Advancements have been made in multiple aspects of diagnostic and therapeutic
approaches to rectal cancer. These advances include clinical staging such as endorectal …

Prospective assessment of EUS criteria for lymphadenopathy associated with rectal cancer

FC Gleeson, JE Clain, GI Papachristou, E Rajan… - Gastrointestinal …, 2009 - Elsevier
BACKGROUND: There are few data that assess the accuracy of echo characteristics for
predicting lymph-node (LN) metastases in patients with rectal cancer. OBJECTIVE: To …

p38 Mitogen-activated protein kinase signalling regulates vascular inflammation and epithelial barrier dysfunction in an experimental model of radiation-induced …

A Mihaescu, S Santén, B Jeppsson… - Journal of British …, 2010 - academic.oup.com
Background Microvascular injury and epithelial barrier dysfunction are rate-limiting aspects
in radiation enteropathy. This study examined the role of p38 mitogen-activated protein …

PrPc deficiency and dasatinib protect mouse intestines against radiation injury by inhibiting of c-Src

C Strup-Perrot, MC Vozenin, V Monceau… - Radiotherapy and …, 2016 - Elsevier
Abstract Background & Aim Despite extensive study of the contribution of cell death and
apoptosis to radiation-induced acute intestinal injury, our knowledge of the signaling …

The use of morphometric and fractal parameters to assess the effects of 5-fluorouracil, interferon and dexamethasone treatment on colonic anastomosis healing: an …

K Łętowska-Andrzejewicz, A Torres… - Folia Histochemica …, 2011 - journals.viamedica.pl
Adjuvant chemotherapy and steroid therapy have been demonstrated to interfere with the
wound healing process. The aim of this study was to evaluate the effects of 5-fluorouracil …

[PDF][PDF] СЕЛЕКТИВНАЯ ЭНДОВАСКУЛЯРНАЯ МАСЛЯНАЯ ЭМБОЛИЗАЦИЯ В КОМПЛЕКСНОМ ЛЕЧЕНИИ ОСЛОЖНЕННОГО РАКА ПРЯМОЙ КИШКИ

СИ Ачкасов - gnck.ru
Заболеваемость колоректальным раком в настоящее время занимает второе место по
частоте среди злокачественных опухолей пищеварительного тракта. По данным …

[引用][C] 多学科协作诊治模式下新辅助化疗对直肠癌术后近期并发症影响的临床对照研究

汪晓东, 曹霖, 曾天芳, 阳川华, 邱萌, 李立 - 中国普外基础与临床杂志, 2008

[引用][C] 新辅助化疗联合生物治疗对低位直肠癌患者免疫功能的影响

王旻, 杨艳明, 刘林林, 张宇, 季福健, 于杰, 房学东 - 中国生物制品学杂志, 2011

[引用][C] Ⅱ/Ⅲ 期直肠癌治疗的现状分析与思考

许卫东, 高军茂 - 医学与哲学(B), 2012

[引用][C] 直肠癌新辅助化疗28 例报告

朱军华, 肖志英, 殷奇 - 亚太传统医药, 2010